搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
7 小时
Merck: A Low-Hanging Fruit To Pick
Merck, a leading global pharmaceutical company that produces a range of medicines, vaccines, and animal healthcare products, ...
腾讯网
13 天
长期价值投资者抄底Merck、看好两只AI潜力股
“Merck本身就很有吸引力,而且它的产品组合特点也非常好,”Oakmark Funds的投资组合经理Nygren在接受CNBC采访时说道。他在第三季度买入了Merck的股票。
2 天
on MSN
Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed ...
About 87.5% of patients treated with the drug were alive after six years, compared to 83.2% who received a placebo.
Daily
9 小时
Merck closes exclusive global license agreement for LM-299
Rahway: Merck, known as MSD outside of the United States and Canada, has announced the closing of the exclusive global ...
9 天
Merck WELIREG获欧盟CHMP积极评价
在当前医学领域,RCC约占所有肾癌病例的最大比例,并且在2020年,欧洲新诊断的RCC案例超过130,000。这意味着,WELIREG的推出不仅会改变患者的命运,也为Merck的肿瘤学研究开辟了一条充满希望的新道路。
4 天
on MSN
Merck's HIV treatment meets main goal in two late-stage studies
Merck's experimental two-drug combination met the main goal of significantly suppressing replication of the HIV-1 virus in ...
6 天
Merck discontinues development of 2 experimental cancer drugs after trial failures
Merck said on Monday it has discontinued the development of two experimental cancer drugs after their failure in several ...
2 天
Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck?
The weight-loss biotech Viking Therapeutics (NASDAQ: VKTX) saw its stock get absolutely slammed on Dec. 18, falling 18% as a ...
6 天
Merck targets 2025 RSV season with antibody now under FDA review
An FDA approval of Merck’s drug clesrovimab by June would give physicians another option for protecting newborns from ...
腾讯网
5 天
翰森制药(03692)与默沙东订立许可协议 将获得1.12亿美元首付款
根据许可协议,许可人将授予被许可人开发、生产及商业化临床前口服小分子 ...
7 天
Merck calls quits on two immunotherapies for cancer
The company is scrapping two drugs aimed at targets called TIGIT and LAG-3, both of which were in the middle of Phase 3 ...
5 天
Merck reaches weight-loss drug deal worth up to $2 billion with China-based Hansoh
Merck announced a weight loss drug deal Wednesday with China-based Hansoh worth up to $2 billion for the pill code-named ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈